Guardant Health Announces Proposed $250M Public Offering Of Common Stock
Portfolio Pulse from Benzinga Newsdesk
Guardant Health, a precision oncology company, has announced a proposed $250 million public offering of its common stock. The company also plans to grant underwriters a 30-day option to purchase up to $37.5 million of its common stock at the public offering price.
May 22, 2023 | 8:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Guardant Health announces a proposed $250M public offering of its common stock, potentially impacting its stock price.
Guardant Health's announcement of a $250M public offering of its common stock may impact its stock price in the short term. The offering is subject to market conditions, and there is no assurance as to whether or when it may be completed, or the actual size or terms of the offering. This uncertainty may lead to neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100